Candida Vaginitis: When Opportunism Knocks, the Host Responds

PLoS Pathogens

Volumn 10, Issue 4, 2014, Pages

  Peters, Brian M ^a   Yano, Junko ^a,b   Noverr, Mairi C ^a,b   Fidel Jr , Paul L ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL VACCINE; C TYPE LECTIN RECEPTOR; DECTIN 1; DECTIN 2; ESTROGEN BINDING PROTEIN; INTERLEUKIN 1BETA; MACROPHAGE INDUCIBLE C TYPE LECTIN; PEPTIDES AND PROTEINS; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; CANDIDA ALBICANS; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; IDIOPATHIC DISEASE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MAINTENANCE THERAPY; MYCOSIS; NONHUMAN; OROPHARYNX CANDIDIASIS; PROTEIN EXPRESSION; QUALITY OF LIFE; SYMPTOMATOLOGY; VAGINA CANDIDIASIS; CANDIDIASIS; ECONOMICS; FEMALE; MICROBIOLOGY; VAGINITIS;

CANDIDA ALBICANS; CANDIDIASIS; FEMALE; HUMANS; VAGINITIS;

EID: 84901326711     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003965     Document Type: Article

References (45)

1. Achkar JM, Fries BC, (2010) Candida infections of the genitourinary tract. Clin Microbiol Rev 23: 253-273.
2. Sobel JD, (1997) Vaginitis. N Engl J Med 337: 1896-1903.
3. Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, et al. (2003) Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother 47: 34-38.
4. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD, (2000) Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis 27: 230-235.
5. Ashman RB, (2008) Protective and pathologic immune responses against Candida albicans infection. Front Biosci 13: 3334-3351.
6. Fidel PL Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R, (1993) Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis 168: 1458-1465.
7. Fong IW, McCleary P, Read S, (1992) Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol 166: 887-890.
8. Mendling W, Koldovsky U, (1996) Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect Dis Obstet Gynecol 4: 225-231.
9. Taylor BN, Saavedra M, Fidel PL Jr, (2000) Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta. Med Mycol 38: 419-431.
10. Wormley FL Jr, Steele C, Wozniak K, Fujihashi K, McGhee JR, et al. (2001) Resistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis. Infect Immun 69: 7162-7164.
11. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, et al. (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299-311.
12. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, et al. (2011) Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS ONE 6: e22770.
13. Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, et al. (2012) The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS ONE 7: e46311.
14. de Bernardis F, Santoni G, Boccanera M, Spreghini E, Adriani D, et al. (2000) Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun 68: 3297-3304.
15. Fidel PL Jr, Barousse M, Espinosa T, Ficarra M, Sturtevant J, et al. (2004) An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 72: 2939-2946.
16. Black CA, Eyers FM, Russell A, Dunkley ML, Clancy RL, et al. (1998) Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect Immun 66: 1273-1275.
17. Peters BM, Palmer GE, Fidel PL Jr, Noverr MC, (2014) Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida vaginitis. Infect Immun 82: 532-543.
18. Yano J, Lilly E, Barousse M, Fidel PL Jr, (2010) Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect Immun 78: 5126-5137.
19. Yano J, Palmer GE, Eberle KE, Peters BM, Vogl T, et al. (2014) Vaginal epithelial cell-derived S100 alarmins induced by C. albicans via pattern recognition receptor interactions is sufficient but not necessary for the acute neutrophil response during experimental vaginal candidiasis. Infect Immun 82: 783-792.
20. Netea MG, Brown GD, Kullberg BJ, Gow NA, (2008) An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6: 67-78.
21. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, et al. (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361: 1760-1767.
22. Rosentul DC, Plantinga TS, Oosting M, Scott WK, Velez Edwards DR, et al. (2011) Genetic variation in the Dectin-1/CARD9 recognition pathway and susceptibility to candidemia. J Infect Dis 204: 1138-1145.
23. Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS, (2003) Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 37: 733-737.
24. Donders GG, Babula O, Bellen G, Linhares IM, Witkin SS, (2008) Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. BJOG 115: 1225-1231.
25. Biswas S, Van Dijck P, Datta A, (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348-376.
26. Moyes DL, Murciano C, Runglall M, Islam A, Thavaraj S, et al. (2011) Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal epithelial cells. PLoS ONE 6: e26580.
27. Taylor BN, Staib P, Binder A, Biesemeier A, Sehnal M, et al. (2005) Profile of Candida albicans-secreted aspartic proteinase elicited during vaginal infection. Infect Immun 73: 1828-1835.
28. Schaller M, Borelli C, Korting HC, Hube B, (2005) Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48: 365-377.
29. Harriott MM, Lilly EA, Rodriguez TE, Fidel PL Jr, Noverr MC, (2010) Candida albicans forms biofilms on the vaginal mucosa. Microbiology 156: 3635-36344.
30. Hong E, Dixit S, Fidel PL, Bradford J, Fischer G (2013) Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J Low Genit Tract Dis.
31. Hamad M, Abu-Elteen KH, Ghaleb M, (2004) Estrogen-dependent induction of persistent vaginal candidosis in naive mice. Mycoses 47: 304-309.
32. Hickey DK, Fahey JV, Wira CR, (2013) Mouse estrous cycle regulation of vaginal versus uterine cytokines, chemokines, alpha-/beta-defensins and TLRs. Innate Immun 19: 121-131.
33. Relloso M, Aragoneses-Fenoll L, Lasarte S, Bourgeois C, Romera G, et al. (2012) Estradiol impairs the Th17 immune response against Candida albicans. J Leukoc Biol 91: 159-165.
34. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L, (2005) Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 206: 306-335.
35. Cheng G, Yeater KM, Hoyer LL, (2006) Cellular and molecular biology of Candida albicans estrogen response. Eukaryot Cell 5: 180-191.
36. Hollmer C, Essmann M, Ault K, Larsen B, (2006) Adherence and blocking of Candida albicans to cultured vaginal epithelial cells: treatments to decrease adherence. Infect Dis Obstet Gynecol 2006: 98218.
37. Madani ND, Malloy PJ, Rodriguez-Pombo P, Krishnan AV, Feldman D, (1994) Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol. Proc Natl Acad Sci U S A 91: 922-926.
38. Zhang X, Essmann M, Burt ET, Larsen B, (2000) Estrogen effects on Candida albicans: a potential virulence-regulating mechanism. J Infect Dis 181: 1441-1446.
39. Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, et al. (2011) The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio 2: e00055-00011.
40. Ma B, Forney LJ, Ravel J, (2012) Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol 66: 371-389.
41. Basso B, Gimenez F, Lopez C, (2005) IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect Dis Obstet Gynecol 13: 207-211.
42. Matzinger P, (2002) The danger model: a renewed sense of self. Science 296: 301-305.
43. Tomalka J, Ganesan S, Azodi E, Patel K, Majmudar P, et al. (2011) A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 7: e1002379.
44. De Bernardis F, Amacker M, Arancia S, Sandini S, Gremion C, et al. (2012) A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models. Vaccine 30: 4490-4498.
45. Ibrahim AS, Luo G, Gebremariam T, Lee H, Schmidt CS, et al. (2013) NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine 31: 5549-5556.